![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
A more recent version of this article appeared on June 1, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 5, 2001
Revised on February 13, 2002
Accepted on March 1, 2002
1 Departament de Biologia Cellular, Facultat de Medicina, Institut d'Investigacions August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain
2 Department of Pharmacology, University of Colorado, Health Science Center, Denver, CO, USA
* Corresponding author. E-mail address: enrich{at}medicina.ub.es.
The epidermal growth factor receptor (EGFR) is a member of the tyrosine kinase receptor family involved in signal transduction and the regulation of cellular proliferation and differentiation. It is also a calmodulin-binding protein. To examine the role of calmodulin in the regulation of EGFR, the effect of calmodulin antagonist, W-13, on the intracellular trafficking of EGFR and the MAPK signaling pathway was analyzed. W-13 did not alter the internalization of EGFR but inhibited its recycling and degradation, thus causing the accumulation of EGF and EGFR in enlarged early endosomal structures. In addition, we demonstrated that W-13 stimulated the tyrosine phosphorylation of EGFR and consequent recruitment of Shc adaptor protein with EGFR, presumably through inhibition of the calmodulin-dependent protein kinase II (CaM kinase II). W-13-mediated EGFR-phosphorylation was blocked by metalloprotease inhibitor, BB94, indicating a possible involvement of shedding in this process. However, MAPK activity was decreased by W-13; dissection of this signaling pathway showed that W-13 specifically interferes with Raf-1 activity. These data are consistent with the regulation of EGFR by calmodulin at several steps of the receptor signaling and trafficking pathways.
This article has been cited by other articles:
|
|
 |
|
  J.-G. Ren, Z. Li, and D. B. Sacks IQGAP1 Integrates Ca2+/Calmodulin and B-Raf Signaling J. Biol. Chem., August 22, 2008; 283(34): 22972 - 22982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cubells, S. V. de Muga, F. Tebar, J. V. Bonventre, J. Balsinde, A. Pol, T. Grewal, and C. Enrich Annexin A6-induced Inhibition of Cytoplasmic Phospholipase A2 Is Linked to Caveolin-1 Export from the Golgi J. Biol. Chem., April 11, 2008; 283(15): 10174 - 10183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Llado, P. Timpson, S. Vila de Muga, J. Moreto, A. Pol, T. Grewal, R. J. Daly, C. Enrich, and F. Tebar Protein Kinase C{delta} and Calmodulin Regulate Epidermal Growth Factor Receptor Recycling from Early Endosomes through Arp2/3 Complex and Cortactin Mol. Biol. Cell, January 1, 2008; 19(1): 17 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Perry, H. Le, and I. I. Grichtchenko ANG II and calmodulin/CaMKII regulate surface expression and functional activity of NBCe1 via separate means Am J Physiol Renal Physiol, July 1, 2007; 293(1): F68 - F77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sengupta, M. J. Ruano, F. Tebar, U. Golebiewska, I. Zaitseva, C. Enrich, S. McLaughlin, and A. Villalobo Membrane-permeable Calmodulin Inhibitors (e.g. W-7/W-13) Bind to Membranes, Changing the Electrostatic Surface Potential: DUAL EFFECT OF W-13 ON EPIDERMAL GROWTH FACTOR RECEPTOR ACTIVATION J. Biol. Chem., March 16, 2007; 282(11): 8474 - 8486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Turner and J. R. Raymond Interaction of Calmodulin with the Serotonin 5-Hydroxytryptamine2A Receptor: A PUTATIVE REGULATOR OF G PROTEIN COUPLING AND RECEPTOR PHOSPHORYLATION BY PROTEIN KINASE C J. Biol. Chem., September 2, 2005; 280(35): 30741 - 30750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Choowongkomon, C. R. Carlin, and F. D. Sonnichsen A Structural Model for the Membrane-bound Form of the Juxtamembrane Domain of the Epidermal Growth Factor Receptor J. Biol. Chem., June 24, 2005; 280(25): 24043 - 24052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Gardiner, J. F. Arthur, M. L. Kahn, M. C. Berndt, and R. K. Andrews Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase Blood, December 1, 2004; 104(12): 3611 - 3617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Valiathan and M. D. Resh Expression of Human Immunodeficiency Virus Type 1 Gag Modulates Ligand-Induced Downregulation of EGF Receptor J. Virol., November 15, 2004; 78(22): 12386 - 12394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Llado, F. Tebar, M. Calvo, J. Moreto, A. Sorkin, and C. Enrich Protein KinaseC{delta}-Calmodulin Crosstalk Regulates Epidermal Growth Factor Receptor Exit from Early Endosomes Mol. Biol. Cell, November 1, 2004; 15(11): 4877 - 4891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Deb, C. M. Coticchia, and R. B. Dickson Calmodulin-mediated Activation of Akt Regulates Survival of c-Myc-overexpressing Mouse Mammary Carcinoma Cells J. Biol. Chem., September 10, 2004; 279(37): 38903 - 38911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Turner, A. K. Gelasco, and J. R. Raymond Calmodulin Interacts with the Third Intracellular Loop of the Serotonin 5-Hydroxytryptamine1A Receptor at Two Distinct Sites: PUTATIVE ROLE IN RECEPTOR PHOSPHORYLATION BY PROTEIN KINASE C J. Biol. Chem., April 23, 2004; 279(17): 17027 - 17037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vanoosthuyse, G. Tichtinsky, C. Dumas, T. Gaude, and J. M. Cock Interaction of Calmodulin, a Sorting Nexin and Kinase-Associated Protein Phosphatase with the Brassica oleracea S Locus Receptor Kinase Plant Physiology, October 1, 2003; 133(2): 919 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. PLANQUE, Y.-X. ZHOU, Y. NISHIYAMA, M. SINHA, M. O'CONNOR-MCCOURT, F. C. ARNETT, and S. PAUL Autoantibodies to the epidermal growth factor receptor in systemic sclerosis, lupus, and autoimmune mice FASEB J, February 1, 2003; 17(2): 136 - 143. [Abstract] [Full Text] [PDF]
|
|
